| Literature DB >> 17764790 |
Samuel Aballéa1, Jose Ramón De Juanes, Marco Barbieri, Monique Martin, Jeremy Chancellor, Itziar Oyagüez, Bertrand Verwee, Nathalie Largeron.
Abstract
An economic evaluation of reducing the age threshold for routine influenza vaccination in Spain from 65 to 50 years was performed. A probabilistic model was used to compare a policy based on a recommendation to vaccinate all adults aged 50-64 with the existing vaccination policy for that age group, during interpandemic periods. Two perspectives were considered: third-party payer (TPP) and societal. Model inputs were obtained primarily from the published literature and validated through expert opinion. From TPP perspective, incremental cost-effectiveness ratios were estimated at euro14,919 per quality-adjusted life-year (QALY) gained and euro9731 per life-year gained. From societal perspective, the corresponding results were euro4149 per QALY and euro2706 per life-year gained. Extending routine influenza vaccination to people over 50 years of age is likely to be cost-effective.Entities:
Mesh：
Substances：
Year: 2007 PMID： 17764790 DOI： 10.1016/j.vaccine.2007.07.033
Source DB: PubMed Journal: Vaccine ISSN： 0264-410X Impact factor: 3.641